Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone-Reference-Cited by-同舟云学术

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

Published:2010-04 Issue:4 Volume:51 Page:620-627
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bowen Deborah A.,Call Timothy G.,Shanafelt Tait D.,Kay Neil E.,Schwager Susan M.,Reinalda Megan S.,Rabe Kari G.,Slager Susan L.,Zent Clive S.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428191003682767

Reference26 articles.

1. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

2. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia

3. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

4. Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia;Journal of Oncology Pharmacy Practice;2023-07-30

2. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias;Leukemia;2023-05-18

3. Ibrutinib in combination with rituximab is highly effective in treatment of steroid refractory autoimmune hemolytic anemia;2022-12-06

4. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review;Cancers;2021-11-19

5. Management of autoimmune complications in patients with lymphoid cancer;Blood;2021-09-13